In vivo 5-fluorouracil and fluoronucleotide T1 relaxation time measurements using the variable nutation angle method

Magnetic Resonance in Medicine

Volumn 52, Issue 1, 2004, Pages 169-173

  Gade, Terence P F ^a   Spees, William M ^a,c   Le, H Carl ^a   Zakian, Kristen L ^a   Ponomarev, Vladimir ^a   Doubrovin, Michael ^a   Gelovani, Juri G ^b   Koutcher, Jason A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c WASHINGTON UNIVERSITY   (United States)

Author keywords

5 fluorouracil; Fluoronucleotides; In vivo; T1 relaxation time; Variable nutation angle

Indexed keywords

METABOLITES; RELAXATION TIME; SPECTRUM ANALYSIS;

5-FLUOROURACIL; FLUORONUCLEOTIDES; IN-VIVO; NUTATION ANGLES; T1 RELAXATION TIME;

TUMORS;

CYTOSINE DEAMINASE; FLUORONUCLEOTIDE; FLUOROURACIL; NUCLEOTIDE; UNCLASSIFIED DRUG; URACIL PHOSPHORIBOSYLTRANSFERASE;

ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CALIBRATION; CARCINOSARCOMA; CONTROLLED STUDY; GENETIC TRANSFECTION; IN VIVO STUDY; MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHANTOM; PREDICTION; QUANTITATIVE ANALYSIS; RAT; RELAXATION TIME; TECHNIQUE; VARIABLE NUTATION ANGLE METHOD;

EID: 4644262658     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.20131     Document Type: Article

References (19)

1. Bachert P. Pharmacokinetics using fluorine NMR in vivo. Prog Nucl Magn Reson Spectrosc 1998;33:1-56.
2. Stevens AN, Morris PG, Iles RA, Sheldon PW, Griffiths JR. 5-fluorouracil metabolism monitored in vivo by 19F NMR. Br J Cancer 1984;50:113-117.
3. Wolf W, Albright MJ, Silver MS, Weber H, Reichardt U, Sauer R. Fluorine-19 NMR spectroscopic studies of the metabolism of 5-fluorouracil in the liver of patients undergoing chemotherapy. Magn Reson Imaging 1987;5:165-169.
4. Wolf W, Presant CA, Servis KL, el-Tahtawy A, Albright MJ, Barker PB, Ring 3rd R, Atkinson D, Ong R, King M, Singh M, Ray M, Wiseman C, Blayney D, Shani J. Tumor trapping of 5-fluorouracil: in vivo 19F NMR spectroscopic pharmacokinetics in tumor-bearing humans and rabbits. Proc Natl Acad Sci USA 1990;87:492-496.
5. Kamm YJ, Peters GJ, Hull WE, Punt CJ, Heerschap A. Correlation between 5-fluorouracil metabolism and treatment response in two variants of C26 murine colon carcinoma. Br J Cancer 2003;89:754-762.
6. Li CW, Negendank WG, Padavic-Shaller KA, O'Dwyer PJ, Murphy-Boesch J, Brown TR. Quantitation of 5-fluorouracil catabolism in human liver in vivo by three-dimensional localized 19F magnetic resonance spectroscopy. Clin Cancer Res 1996;2:339-345.
7. Holland SK, Bergman AM, Zhao Y, Adams ER, Pizzorno G. 19F NMR monitoring of in vivo tumor metabolism after biochemical modulation of 5-fluorouracil by the uridine phosphorylase inhibitor 5-benzylacyclouridine. Magn Reson Med 1997;38:907-916.
8. Keniry M, Benz C, Shafer RH, James TL. Noninvasive spectroscopic analysis of fluoropyrimidine metabolism in cultured tumor cells. Cancer Res 1986;46(4 Pt 1):1754-1758.
9. 1 relaxation, a reevaluation of a rapid "new" method for determining NMR spin-lattice relaxation times. J Magn Reson 1985;63:287-297.
10. Gupta RK. A new look at the method of variable nutation angle for the measurement of spin-lattice relaxation times using Fourier transform NMR. J Magn Reson 1977;25:231-235.
11. Christenseri KA, Grant DM, Schulman EM, Walling C. Optimal determination of relaxation times of Fourier transform nuclear magnetic resonance. Determination of spin-lattice relaxation times in chemically polarized species. J Phys Chem 1974;78:1971-1977.
12. Sakuma H, Nelson SJ, Vigneron DB, Hartiala J, Higgins CB. Measurement of T1 relaxation times of cardiac phosphate metabolites using BIR-4 adiabatic RF pulses and a variable nutation method. Magn Reson Med 1993;29:688-691.
13. Fram EK, Herfkens RJ, Johnson GA, Glover GH, Karis JP, Shimakawa A, Perkins TG, Pelc NJ. Rapid calculation of T1 using variable flip angle gradient refocused imaging. Magn Reson Imaging 1987;5:201-208.
14. Ng TC, Glickson JD. Shielded solenoidal probe for in vivo NMR studies of solid tumors. Magn Reson Med 1985;2:169-175.
15. Ballon D, Mahmood U, Jakubowski A, Koutcher JA. Resolution enhanced NMR spectroscopy in biological systems via magnetic susceptibility matched sample immersion chambers. Magn Reson Med 1993;30:754-758.
16. Naressi A, Couturier C, Devos JM, Janssen M, Mangeat C, de Beer R, Graveron-Demilly D. Java-based graphical user interface for the MRUI quantitation package. MAGMA 2001;12:141-152.
17. Selinsky BS, Perlman ME, London RE. In vivo nuclear magnetic resonance studies of hepatic methoxyflurane metabolism. I. Verification and quantitation of methoxydifluoroacetate. Mol Pharmacol 1988;33:559-566.
18. Michaelis T, Merboldt KD, Bruhn H, Hanicke W, Frahm J. Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology 1993;187:219-227.
19. Klomp DW, Van Laarhoven HW, Kentgens AP, Heerschap A. Optimization of localized 19F magnetic resonance spectroscopy for the detection of fluorinated drugs in the human liver. Magn Reson Med 2003;50:303-308.